During gestation, obese pregnant women exhibit greater insulin resistance compared to non-obese pregnant women, higher levels of plasma insulin, IGF-1, leptin, and lower plasma adiponectin concentrations, which activate mTOR-mediated placental protein synthesis and may be associated with an increased risk of fetal macrosomia and GDM. The gene discussed is LEP; the disease is gestational diabetes.